219 related articles for article (PubMed ID: 32912061)
1. Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways.
Alhosin M; Razvi SSI; Sheikh RA; Khan JA; Zamzami MA; Choudhry H
Technol Cancer Res Treat; 2020; 19():1533033820947489. PubMed ID: 32912061
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis.
Abusnina A; Alhosin M; Keravis T; Muller CD; Fuhrmann G; Bronner C; Lugnier C
Cell Signal; 2011 Jan; 23(1):152-60. PubMed ID: 20807569
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1.
Alhosin M; Abusnina A; Achour M; Sharif T; Muller C; Peluso J; Chataigneau T; Lugnier C; Schini-Kerth VB; Bronner C; Fuhrmann G
Biochem Pharmacol; 2010 May; 79(9):1251-60. PubMed ID: 20026309
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms.
Qadi SA; Hassan MA; Sheikh RA; Baothman OA; Zamzami MA; Choudhry H; Al-Malki AL; Albukhari A; Alhosin M
Epigenet Insights; 2019; 12():2516865719839011. PubMed ID: 31058255
[TBL] [Abstract][Full Text] [Related]
5. The Potential Role of
Alsanosi S; Sheikh RA; Sonbul S; Altayb HN; Batubara AS; Hosawi S; Al-Sakkaf K; Abdullah O; Omran Z; Alhosin M
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566130
[No Abstract] [Full Text] [Related]
6. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.
Abdullah O; Omran Z; Hosawi S; Hamiche A; Bronner C; Alhosin M
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922029
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
8. Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.
Hwang WY; Park WH; Suh DH; Kim K; Kim YB; No JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638596
[TBL] [Abstract][Full Text] [Related]
9. Role of epigenetic regulation on the induction of apoptosis in Jurkat leukemia cells by white grape pomace rich in phenolic compounds.
León-González AJ; Jara-Palacios MJ; Abbas M; Heredia FJ; Schini-Kerth VB
Food Funct; 2017 Nov; 8(11):4062-4069. PubMed ID: 28976514
[TBL] [Abstract][Full Text] [Related]
10. Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity.
Mehrpouri M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M; Bashash D
Eur J Pharmacol; 2020 May; 875():173050. PubMed ID: 32142770
[TBL] [Abstract][Full Text] [Related]
11. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
13. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.
Pang J; Shen N; Yan F; Zhao N; Dou L; Wu LC; Seiler CL; Yu L; Yang K; Bachanova V; Weaver E; Tretyakova NY; Liu S
Oncotarget; 2017 May; 8(21):34453-34467. PubMed ID: 28415607
[TBL] [Abstract][Full Text] [Related]
15. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
16. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
17. Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts.
Alhosin M; Ibrahim A; Boukhari A; Sharif T; Gies JP; Auger C; Schini-Kerth VB
Invest New Drugs; 2012 Oct; 30(5):1813-9. PubMed ID: 21881916
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
Fatfat M; Fakhoury I; Habli Z; Mismar R; Gali-Muhtasib H
Life Sci; 2019 Sep; 232():116628. PubMed ID: 31278946
[TBL] [Abstract][Full Text] [Related]
19. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
Selamnia M; Mayeur C; Robert V; Blachier F
Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
